Estrogen-related receptor
From Proteopedia
(Difference between revisions)
| Line 17: | Line 17: | ||
</StructureSection> | </StructureSection> | ||
| - | ==3D structures of estrogen-related receptor== | ||
| - | |||
| - | Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | ||
| - | {{#tree:id=OrganizedByTopic|openlevels=0| | ||
| - | |||
| - | *ERR | ||
| - | |||
| - | **[[1xb7]], [[3d24]] – hERR ligand-binding domain + peroxisome proliferator activated receptor coactivator 1 peptide – human<br />[[2pjl]] - hERR ligand-binding domain (mutant) + inverse agonist<br /> | ||
| - | **[[3k6p]] - hERR ligand-binding domain + ligand | ||
| - | |||
| - | *ERRβ | ||
| - | |||
| - | **[[1lo1]] – hERR DNA-binding domain + DNA - NMR | ||
| - | |||
| - | *ERRγ | ||
| - | |||
| - | **[[2gp7]], [[2zbs]] - hERR ligand-binding domain<br /> | ||
| - | **[[1kv6]], [[1tfc]] – hERR ligand-binding domain + steroid receptor coactivator 1 2nd NR-Box <br /> | ||
| - | **[[2gpo]], [[2gpp]] - hERR ligand-binding domain + nuclear receptor-interacting protein 1 peptide<br /> | ||
| - | **[[2ewp]] - hERR ligand-binding domain + tamoxifen analog<br /> | ||
| - | **[[2gpu]], [[2p7z]] - hERR ligand-binding domain + 4-hydroxytamoxifen<br /> | ||
| - | **[[2e2r]], [[2p7g]] - hERR ligand-binding domain + bisphenol A<br /> | ||
| - | **[[2zkc]] - hERR ligand-binding domain + bisphenol Z<br /> | ||
| - | **[[2zas]] - hERR ligand-binding domain + bisphenol A derivative<br /> | ||
| - | **[[6a6k]], [[5yso]] - hERR ligand-binding domain + piperazine derivative<br /> | ||
| - | **[[2p7a]] - hERR ligand-binding domain + methyl phenol<br /> | ||
| - | **[[2gpv]] - hERR ligand-binding domain + nuclear receptor corepressor 2 peptide + 4-hydroxytamoxifen<br /> | ||
| - | **[[1s9p]], [[1s9q]] - mERR ligand-binding domain + diethylstilbesterol – mouse<br /> | ||
| - | **[[1vjb]] - mERR ligand-binding domain + 4-hydroxytamoxifen<br /> | ||
| - | }} | ||
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 10:22, 23 June 2019
| |||||||||||
References
- ↑ Ariazi EA, Jordan VC. Estrogen-related receptors as emerging targets in cancer and metabolic disorders. Curr Top Med Chem. 2006;6(3):203-15. PMID:16515477
- ↑ Wang L, Zuercher WJ, Consler TG, Lambert MH, Miller AB, Orband-Miller LA, McKee DD, Willson TM, Nolte RT. X-ray crystal structures of the estrogen-related receptor-gamma ligand binding domain in three functional states reveal the molecular basis of small molecule regulation. J Biol Chem. 2006 Dec 8;281(49):37773-81. Epub 2006 Sep 21. PMID:16990259 doi:http://dx.doi.org/10.1074/jbc.M608410200
